Skip to main content

Third #Update on #Developments in #Iran {War} (June 22 '25)

Image
By G.M.



A large nuclear complex in Esfahan has been targeted for a second time during Israel’s attacks on Iran over the past nine days, with several more buildings struck, Director General Rafael Mariano Grossi of the International Atomic Energy Agency (IAEA) said today.

The site in central Iran was first hit on 13 June when four buildings were damaged: the central chemical laboratory, a uranium conversion facility, a reactor fuel manufacturing plant, and an enriched uranium metal processing facility under construction. No increase of off-site radiation levels was reported.

Based on information available to the IAEA today, six other buildings at the same site have now also been attacked: a natural and depleted uranium metal production facility which had not yet begun operations, a fuel rod production facility, a building with low-enriched uranium pellet production as well as a laboratory and nuclear material storage, another laboratory building, a workshop handling contaminated equipment and an office building with no nuclear material.

The same Esfahan complex includes a centrifuge manufacturing workshop that the IAEA earlier today reported had also been hit by Israel.

The facilities targeted today either contained no nuclear material or small quantities of natural or low enriched uranium, meaning any radioactive contamination is limited to the buildings that were damaged or destroyed.

“This nuclear complex in Esfahan – one of the key sites of the Iranian nuclear programme – has repeatedly been attacked and extensively damaged. Based on our analysis of the nuclear material present, we don’t see any risk of off-site contamination. Nevertheless, as I have repeatedly stated, nuclear facilities should never be attacked,” Director General Grossi said.   

Source: International Atomic Energy Agency,  https://www.iaea.org/newscenter/pressreleases/update-on-developments-in-iran-3

____

Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »